Market Overview

CLSA Launches 'Faces of California Biomedical Innovation' Campaign to Highlight Impact of Life Sciences Treatments on California Patients and Their Families


New Digital Ad Campaign to Elevate Patient Voices through Video
Testimonial Series, New ‘
Access and Innovation
' Web Hub and Advocacy Launchpad

Life Sciences Association
(CLSA), the trade association representing
California's life sciences industry, today announced the launch of "Faces
of California Biomedical Innovation
," a digital campaign to elevate
and amplify California patient voices and showcase the impact of
innovative cures and treatments developed by the California life
sciences industry.

As part of the campaign, CLSA is launching a new website and advocacy
that provides visitors with facts, figures, petitions, shareable
infographics, and news about California's innovation economy; a series
of patient testimonial videos; and a new digital ad campaign to elevate
the voices of Californians across the state. The California life
sciences cluster employs nearly 1 million people statewide and has
approximately 1,300 new therapies in the development pipeline from more
than 3,200 life sciences companies.

"California's life sciences industry is helping improve and save lives
every day in California and around the world. This ‘Faces
of California Biomedical Innovation
' campaign will help elevate the
voices of California patients and their families and highlight how
biomedical industry research, development, and delivery of innovative
medical treatments has positively impacted their lives," said CLSA
President and CEO Sara Radcliffe. "By empowering patients to tell their
own stories and sharing these testimonies in California and beyond, CLSA
and our members are also delivering a powerful message to lawmakers in
Sacramento and Washington, D.C., about the importance of protecting the
California innovation economy and the life-saving treatments it
produces, and avoiding policies that will harm this ecosystem."

All first-person patient testimonials urge California legislators in
Congress and Sacramento to safeguard life-saving innovation and include
three segments: 1) Protect California biomedical innovation; 2) Protect
access to care; and 3) What would you tell policymakers. The initial
patients in the CLSA video series include:

  • Jeff Finerman, who was diagnosed with advanced stage prostate cancer
    when he was 67 years old. Thanks to biomedical treatments researched
    and developed in California, Jeff has been able to see his twin
    daughters excel in high school and live a healthier, fuller life. Jeff
    says: "You can't put a value on curing someone from potential death." Click
    here to watch Jeff's full story
  • Evaleen Minez Harris, a Bay Area resident and mother of two, who was
    diagnosed with peripartum cardiomyopathy shortly after the birth of
    her twins. She was rushed into surgery and had the HeartMate 3TM
    left ventricular assist device (LVAD) implanted. This medical device
    is currently saving her life while she waits for a heart transplant. Watch
    Evaleen's full story here
  • California native Deborah Goldberg, who is working to beat colorectal
    cancer thanks to the state-of-the-art treatments developed by the
    California biomedical community. Deborah and her husband are extremely
    thankful she had access to innovative cancer treatments and is alive
    today. Meet
    Deborah and see how critical the California biomedical industry has
    been to her battle with cancer
  • Vance Sharp III, who was suffering from congestive heart failure, and
    who had few options left when he had a HeartMate 3TM LVAD
    implanted. Thanks to this device, Vance can continue living out the
    golden years with his wife Monika and be with his two daughters into
    their adulthood. Hear
    how medical innovations developed in California are helping Vance live
    a normal, active life

"CLSA is proud to be at the forefront of utilizing new and innovative
communications tactics to help tell the stories of patients whose lives
have been positively impacted by treatments and cures developed by the
life sciences sector," said CLSA Communications Director Will Zasadny.
"This new campaign will bolster our efforts to educate policymakers on
the contributions innovative life scientists and CLSA member companies
make to improve patient care."

Visit the newly launched website at
to view the digital campaign and get involved. Additional patient
stories will be introduced throughout the year focusing on advancements
in biomedical innovation from California companies. Californians can
join the conversation by using #FacesofCABiomedicalInnovation
or signing up here
to share their story.

For reporters interested in broadcast quality video, please contact Will
Zasadny, Director, Communications (

  • Learn
     about the California life sciences industry
  • View CLSA's
    Legislative Action Center
  • View
    CLSA's Advocacy Priorities
  • View upcoming
    CLSA events

About California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA) is the state's largest and
most influential life sciences advocacy and business leadership
organization. With offices in Sacramento, San Diego, South San
Francisco, Los Angeles and Washington DC, CLSA works closely with
industry, government, academia and others to shape public policy,
improve access to innovative technologies and grow California's life
sciences economy. CLSA serves biotechnology, pharmaceutical, medical
device and diagnostics companies, research universities and institutes,
investors and service providers throughout the Golden State. CLSA was
founded in 2015 when the Bay Area Bioscience Association (BayBio) and
the California Healthcare Institute (CHI) merged. Visit CLSA at,
and follow us on Twitter @CALifeSciences,
LinkedIn and

View Comments and Join the Discussion!